Intracellular signaling pathways not only control cell proliferation and survival, but also regulate the provision of cellular energy and building blocks through mitochondrial and nonmitochondrial metabolism. Wild-type and oncogenic RAF kinases have been shown to prevent apoptosis following the removal of interleukin 3 (IL-3) from mouse pro-myeloid 32D cells by reducing mitochondrial reactive oxygen species production. To study primary effects of RAF on mitochondrial energy metabolism, we applied high-resolution respirometry after short-term IL-3 deprivation (8 h), before 32D cells show detectable signs of cell death. Respiration in intact 32D cells was suppressed as an early event following removal of IL-3, but remained more stable in 32D cells expressing the v-RAF oncogene. In permeabilized 32D cells deprived of IL-3, respiratory capacities of the NADH-pathway, the convergent NADH&succinate-pathway, and Complex IV activity were decreased compared to cells grown in the presence of IL-3, whereas succinate-supported respiration remained unchanged, consistent with control by Complex IV.
Introduction
RAF serine-threonine kinases are evolutionary highly conserved components of cellular signal transduction, which promote cell growth, transformation and survival 1, 2 . The RAF kinase family comprises the originally identified viral oncogene v-RAF and the subsequently cloned proto-oncogenes CRAF, ARAF and BRAF 3 . In melanoma, the activation of the mitogen-activated protein kinase pathway by BRAF mutants has been shown to be the primary cause of malignant transformation 4 .
The anti-apoptotic function of CRAF is well documented by overexpression and gene knockout studies 5 . Cell death is increased in CRAF and BRAF deficient animals [6] [7] [8] [9] [10] [11] .
Treatment with BRAF inhibitors significantly improves the survival of patients with metastatic melanoma 4 . The mitochondrion is a key organelle involved in the regulation of apoptosis.
Studies on the control of cell survival by CRAF suggest a role for this kinase in maintaining mitochondrial (mt) integrity and counteracting induction of apoptosis (reviewed by 5 ). In vascular endothelial cells, fibroblast growth factor induces CRAF translocation and its binding to mitochondria through the N-terminal domain (reviewed by 12 ). Cells are protected from apoptosis when RAF accumulates in the mitochondria 8, 13, 14 .
Crosstalk between mitochondria and other compartments of the cell has important regulatory functions and is mediated by small molecules, such as reactive oxygen species (ROS) and Ca 2+ , and by components of intracellular signaling pathways [15] [16] [17] . Oncogenically activated signaling proteins are implicated in the metabolic rewiring of tumor cells including the wellestablished shift from oxidative phosphorylation to glycolysis under normoxic condition 4, 18, 19 . Thus the frequently mutated RAS oncogene, an essential upstream component in the activation of RAF kinases, exerts many effects on mitochondria including an increase in mtmass, mtDNA content 20 , concentrations of tricarboxylic acid (TCA) cycle intermediates 21 , and modifications of mt shape and distribution 13 . Furthermore, RAS, located upstream of RAF protein in the RAS/RAF/MEK pathway, is linked to an increase in mt-production of ROS 20, 22, 23 . K-RAS protein is localized to the mitochondria and causes mt-respiratory dysfunction at an early time point 24 . In fact, more than a third of human tumors present an activated mutant RAS oncogene 25, 26 .
Small GTPases of the RAS family have effectors other than RAFs. Some studies demonstrate increased ROS levels in cells transformed by RAS 23 , whereas RAF-transformed cells upregulate defense mechanisms by increasing antioxidant capacity 27, 28 . In hepatocellular carcinoma cells resistant to treatment by the multikinase inhibitor sorafenib also targeting RAF, activating oxidative phosphorylation (OXPHOS) by the pyruvate dehydrogenase kinase inhibitor dichloroacetate markedly sensitizes the cancer cells to apoptosis 29, 30 . A similar observation has been reported for melanoma cells carrying the activating V600E mutation in BRAF 18 . Mutant BRAF in melanoma cells downregulates expression of PGC1α, a member of the superfamily of transcriptional co-activators that promote mitochondrial biogenesis and enhance OXPHOS (see review 4 ). A recent study in pancreatic β cells provides further evidence that the increase in mitochondrial respiration triggered by PKC is in part mediated through CRAF 31 . While these studies illustrate the profound role of RAF kinases in reprogramming tumor cell metabolism and preventing cell death, they do not address a possible direct effect of RAF on OXPHOS and bioenergetic coupling at earlier time points, which precede the onset of apoptotic cell death.
The goal of our study was to analyze mitochondrial respiratory function after a short absence of growth factor with the known consequences on the shutdown of intracellular signaling cascades, as it may occur in vivo during stroke or ischemia/reperfusion in solid organ transplantation. Focusing on an early time point, before any molecular signals of apoptosis can be detected, we demonstrated that the significant decline of mitochondrial respiratory capacity is the earliest elucidated effect of growth factor removal. Loss of mt-function was effectively suppressed by oncogenic RAF (v-RAF), suggesting for the first time a direct link between the key mitogenic and survival kinase CRAF and mitochondrial energy homeostasis.
Results
Cell survival and protein content are preserved at an early time point of growth factor withdrawal IL-3 withdrawal from 32D cells (32D-IL3) provides a unique system for the study of cellular alterations that precede the onset of apoptotic cell death. Absence of growth factor for 24 h reproducibly results in apoptosis of 80% of the parental 32D cells and in only 20% of the 32D cells expressing v-RAF (32Dv-RAF cells) 32 . Activated RAF prevents late mitochondrial events preceding cell death, e.g., increase in ROS and mitochondrial Ca 2+ 27, 28 . The present study focuses on the earliest changes following growth factor removal. IL-3 deprivation for 8 h resulted in no detectable signs of cell death ( Fig. 1A) . Re-addition of IL-3 at the end of the 8h starvation period prevented subsequent cell death. In all our experiments, the starting cell viability was higher than 96% and remained unchanged after 8 h of IL-3 withdrawal in 32D and 32Dv-RAF cells. A significant decrease in cell volume was observed in 32D cells [0.4 (0.83-1.37) pL versus 0.79 (0.69-0.93) pL] but not in v-RAF protected cells ( Table 1) . Regardless of the decrease in cell volume, the protein content of 32D and 32Dv-RAF cells was not significantly different after IL-3 withdrawal (Table 1) . Furthermore, IL-3 withdrawal for 8 h did not cause detectable effects on cell cycle distribution ( Table 2) . ROUTINE respiration is the activity of intact cells in culture medium (RPMI) containing exogenous substrates which support energy metabolism and biosynthesis. LEAK respiration is the minimum respiration compensating mainly for proton leak after inhibition of ATP synthase by olygomycin. ETS is the maximal electron transfer capacity at optimum uncoupler concentration. Complexes I and III were inhibited by rotenone and antimycin A for measurement of residual oxygen consumption (ROX). (C) Box plots indicate the minimum, 25 th percentile, median, 75 th percentile, and maximum (n=8 replicates; N=3 independent cultures). * Significantly different (p<0.05) after IL-3 withdrawal. # A latent injury was revealed in samples when uncoupler titration following oligomycin resulted in respiration not stimulated above the ROUTINE level. Since the actual ETS capacity cannot be lower than ROUTINE respiration, these data are excluded from the graph (excl). 
Cell cycle phase
Activated RAF protects mitochondrial function during growth factor deprivation, while mitochondrial and glycolytic marker enzymes are preserved ROUTINE respiration (R) of intact 32D cells was suppressed significantly after 8 h growth factor deprivation ( Fig. 1 ). The decline was not significant in 32Dv-RAF cells (Fig. 1C ),
suggesting that the presence of activated RAF was sufficient to prevent this early change caused by IL-3 withdrawal. Resting oxygen consumption that compensates for proton leak, electron slip and cation cycling (LEAK respiration, L), was measured by inhibition of ATP-synthase with oligomycin ( Fig. 1B) . LEAK respiration was significantly suppressed in 32D cells after 8 h growth factor deprivation (Fig. 1C ). The decrease in LEAK respiration following IL-3 removal, however, was not prevented by v-RAF overexpression. Electron transfer system (ETS) capacity (E) was estimated by uncoupling the cells with optimal concentrations of the protonophore FCCP (Fig. 1B) . The apparent ETS excess capacity above ROUTINE respiration, E-R, was identical in 32D and 32-v-RAF cells (Fig. 1C ). ETS capacity declined not significantly in 32-v-RAF cells after IL-3 removal. 32D-IL3 cells, however, presented a latent injury revealed by uncoupler titration after oligomycin treatment, when respiration was unstable and flux was occasionally not even stimulated to the level of ROUTINE respiration (data not shown). An appropriate estimation of ETS capacity was not possible in those cells after inhibition by oligomycin.
Activities of the mitochondrial marker enzyme citrate synthase (CS) and the glycolytic marker enzyme lactate dehydrogenase (LDH) expressed in units per million cells did not differ significantly between parental and v-RAF expressing 32D cells and were not significantly reduced by IL-3 deprivation ( Table 1) . Variations in the activities of these marker enzymes were directly correlated, suggesting no re-programming of glycolytic versus aerobic metabolism under the prevailing growth conditions ( Fig. 2 ). 10 and 20 µg•ml -1 ). 10 µM cytochrome c (4c) did not significantly stimulate respiration, indicating that the outer mt-membrane remained intact even at the highest digitonin concentration.
Growth factor deprivation causes a defect in OXPHOS and ETS capacity and cytochrome c release
In order to assess specific defects that cause the decrease in mitochondrial respiratory function after IL-3 removal in the 32D cells, we applied OXPHOS analysis in cells permeabilized by digitonin. Cells treated with an apoptosis inducer show a change in the sensitivity of the outer mt-membrane to digitonin 33 . Therefore, we tested permeabilization of the cell membrane by digitonin in 32D and 32Dv-RAF cells grown in the presence or absence 
Complex IV is the main respiratory control variable of mitochondrial injury in 32D cells
Cytochrome c oxidase (Complex IV; CIV) is the terminal enzyme in the mitochondrial electron transfer system. Measurement of the enzyme activity of this single step in the pathway of oxygen consumption constitutes a key element in OXPHOS analysis 43 To gain insight into the possible mechanisms underlying the reduction of respiratory capacity in IL-3 starved 32D cells, we tested the hypothesis that the change in mitochondrial respiration was caused by a general decrease in mitochondrial content or by a switch from aerobic to glycolytic pathways. In specific tumors, a mitochondrial injury causing an increased dependence on glycolysis for ATP production is well documented (Warburg effect, see reviews [35] [36] [37] [38] [39] ). We therefore assayed citrate synthase (CS), an enzyme of the TCA cycle, as a marker of mitochondrial content and lactate dehydrogenase as a glycolytic marker. The results show that the decrease in respiration cannot be explained by an enzymatic switch to glycolysis, since the activities of the two marker enzymes varied in direct proportion, without a significant change Our data exclude cell size and mitochondrial content as explanations of the decrease of respiration in intact 32D cells after IL-3 withdrawal. Two other possible explanations for the decrease in ROUTINE respiratory activity are a shift to a metabolic state with lower energy demand, or mitochondrial injuries. Inhibition of intact cell respiration by the CI inhibitor rotenone (Fig. 3) is frequently thought to provide a diagnostic measure of electron flow through the NADH-pathway, when rotenone suppresses most of the respiratory activity 24 . This interpretation ignores the fact that inhibition of CI simultaneously prevents formation of succinate in the TCA cycle, since succinate production is stopped when NADH cannot be oxidized by CI. Without cytosolic sources of succinate, therefore, rotenone inhibition of cell respiration does not exclusively inhibit electron flux through CI, but simultaneously suppresses the succinate-pathway flux by redox-coupling in the TCA cycle.
In the N-pathway, pyruvate, malate and glutamate dehydrogenases reduce NAD + to NADH, feeding electrons into CI. Electrons are further transferred through CIII and CIV to oxygen, the final electron acceptor (N; Fig. 5C ). CI, CIII and CIV are frequently arranged as supercomplexes 40, 41 . When succinate is provided, electrons are transferred though succinate dehydrogenase (CII) to CIII and CIV (S; Fig. 5C ). N-and S-pathway capacities were 0.50 and 0.60, respectively, of convergent NS-pathway capacity, thus exerting an almost completely additive effect on the combined pathway (NS; Fig. 5C ). When measured separately, pathway control resides upstream of the Q-junction, and downstream catalytic capacities are in excess ( Fig. 5C ). When Complex IV is in excess, pathway flux does not decrease proportionally to inhibition of CIV activity due to a threshold effect. In most types of mitochondria, CIV is in excess of electron transfer pathway capacity, even at maximal upstream electron supply by the convergent NS-pathway 42, 43 . In macrophage cells the apparent excess CIV capacity, (CIV-NS)/NS, is 0.46 44 . Similarly, in a variety of intact human cell lines, the apparent excess CIV capacity in intact uncoupled cells varies between 0.00 and 0.40 [45] [46] [47] . In 32D cells, the excess CIV-NS capacity was practically zero. This suggests that CIV is the main respiratory control variable of mitochondrial injury in 32D cells. The observation of a preserved S-pathway capacity (Fig. 4C) does not contradict this conclusion, but provides evidence of a significant excess CIV capacity with respect to the S-pathway. The corresponding CIV threshold increases as the S/NS flux control ratio declines 43 . Since the S/NS flux control ratio was as low as 0.6 ( Fig. 5C ), S-pathway capacity is not expected to decline as long as inhibition of CIV does not exceed 40% (Fig. 5B ). An exclusive defect of CIV, however, cannot explain the significant decline of N-OXPHOS capacity, since the N/NS flux control ratio was even lower than S/NS, indicating an additional defect upstream of the Q-junction or in the CI+CIII+CIV supercomplex ( Fig. 5C ). In physiological states with convergent NS-electron flow, the apparent excess capacity of downstream electron transfer is lower and flux control is shifted towards CIII and CIV.
Cytochrome c normally resides in the inner mt-membrane and is an essential component of the respiratory system, responsible for electron transfer from CIII to cytochrome c oxidase 48 . Cytochrome c is an important apoptogenic factor, since its release from the mitochondrial intermembrane space initiates caspase activation which leads to apoptotic cell death [49] [50] [51] [52] . The respirometric stimulation by addition of exogenous cytochrome c is an indirect method to show permeability of the outer mt-membrane and release of cytochrome c to the cytosol. In the 32D cells deprived of IL-3 for 8 h, cytochrome c release was detected to a small extent, without significant increase in cell death or uncoupling. Mitochondria remained highly coupled even after IL-3 withdrawal, as shown by high OXPHOS coupling efficiencies in the range of 0.72 to 0.90 measured in the N-pathway control state with PGM. This agrees with results on leukemia cells undergoing apoptosis 34 . Expression of v-RAF residing in the outer mitochondrial membrane had also been shown previously to protect 32D cells 53 , human leukemia cells 34 and fibroblasts 8 by preventing cytochrome c release and subsequent activation of caspases 53 . A possible explanation for the RAF-induced inhibition of cytochrome c release in growth factor starved cells is the formation of a complex with the voltage-dependent anion channel (VDAC or porin; 53 a mitochondrial protein involved in the exchange of metabolites for oxidative phosphorylation 54 ). The new complex formed in vivo blocks reconstitution of VDAC channels in planar bilayer membranes in vitro 53 . It is surprising, however, that cytochrome c release was detected at this early time point, when the 32D cells are still not presenting any increase in mortality and can fully recover if they are provided again with IL-3. These findings suggest that the cells deprived of IL-3 may have become more sensitive and experience some mitochondrial membrane fragility.
Our study provides novel insights into a key pathway involved in malignant transformation. Mitochondrial dysfunction is triggered by growth factor limitation, which is a critical step in cancer progression, when the increased size of the growing tumor affects the diffusion of oxygen and nutrients. The viral oncogene v-RAF has been discovered 55 long before mutations were detected in human BRAF 56 and CRAF 1 . The murine homolog BRAF, therefore, might currently be considered as the most relevant oncogene. However, many key findings regarding signaling by oncogenic RAF have been initially obtained with v-RAF and were confirmed later with oncogenic variants of BRAF and CRAF. This suggests that the effects of activated RAF on mitochondrial physiology plays out in human tumors carrying mutant forms of BRAF or CRAF.
Our results demonstrate that IL-3 withdrawal severely compromises mitochondrial respiratory function in a fashion that is suppressible by v-RAF. This suggests a direct link between the key mitogenic and survival kinase CRAF and mitochondrial energy homeostasis. 
Materials and Methods

Cell culture
Experiments were performed with the parental promyeloid interleukin-3 (IL-3)dependent cell line 32D and with 32Dv-RAF cells expressing activated CRAF 32, 61 . Cells were grown in RPMI 1640 (PAA Laboratories Pasching, Austria) supplemented with fetal calf serum (10%, heat-inactivated 45 min at 56 °C), 100 U of penicillin (100 U·ml -1 ; Invitrogen, Carlsbad, CA), streptomycin (100 U·ml -1 ; Invitrogen, Carlsbad, CA), L-glutamine (2 mM; Invitrogen, Carlsbad, CA) and WEHI cell-conditioned medium (15%). Every three days cells were split at a ratio of 1:10 and refed with fresh medium. Cell viability was determined by trypan blue exclusion assay and cells were used in experiments only when the viability was above 97%.
For starvation experiments cells were washed three times in IL-3 free RPMI 1640 and resuspended in RPMI 1640 without IL-3 at a cell density of 0.5·10 6 cells·ml -1 and incubated for 8 h (Fig. 1A) . Measurement of respiration in intact cells was performed in RPMI (density 1·10 6 cells·ml -1 ). For the cell permeabilization test and the measurement of respiration in permeabilized cells, cells were rinsed twice with respiration medium MIR05 (110 mM sucrose/ taurine/ 10 mM KH2PO4/ 20 mM K-HEPES/ pH 7.1 62 ) , and diluted to a concentration of 2•10 6 cells•ml -1 in MiR05.
Cell size determination
Cell volume was analysed in a CASY1 TT cell counter and analyser system (Schärfe System, Reutlingen, Germany) which combines the techniques of particle measurement and pulse area analysis signal processing. Cell suspensions were diluted in isotonic CASY Ton® solution (100 µl in 10 ml) and introduced into the sensor through a capillary. Every cell is recorded with a frequency of 10 6 evaluations per second during the pulse area analysis while passing through the sensor and the individual signals are analysed according to form, width, range and time frame. Events in the range of 6-25 µm diameter were included in the calculation.
Cell cycle analysis
Cells were washed with 3 ml ice cold PBS and the pellet was resuspended in 500 µl ice cold PBS and 5 ml cold absolute ethanol added dropwise. Samples were centrifuged and supernatant was discarded. After a final wash with 5 ml ice cold PBS containing 1% BSA, samples were resuspended in 250 µl DNA staining buffer containing sodium citrate (1 mg·ml -1 ),
Triton-X 100 (150 µl·ml -1 ), propidium iodide (0.1 mg·ml -1 ) and Ribonuclease A (0.02 mg·ml -1 ) and incubated at 37 °C for 30 min. Propidium iodide fluorescence was measured using linear FL2 channel in a FACSCalibur flow cytometer (Beckton Dickinson) and analyzed using Cellquest software. Resulting peaks corresponded with cell cycle states A, G1, S and G2 63 .
Areas were set to calculate the four peaks in terms of percent of gated events and mean fluorescence intensity.
High-resolution respirometry: Cell survival was assayed before each experiment by staining with trypan blue. Cell respiration was measured at 37 °C with the Oxygraph-2k (Oroboros Instruments, Innsbruck, Austria) in 2-ml chambers at a stirrer speed of 750 rpm. Data acquisition and real-time analysis were performed using the software DatLab (Oroboros Instruments, Innsbruck, Austria). Automatic instrumental background corrections were applied for oxygen consumption by the polarographic oxygen sensor and oxygen diffusion into the chamber 64 . were treated with corresponding titrations of ethanol, and no effect was detected.
Plasma membrane permeabilization:
The optimum digitonin concentration for selective permeabilization of the plasma membrane was determined in 32D and 32Dv-RAF cells grown in the presence of IL-3 or after 8 h IL-3 withdrawal. The cell density for the permeabilization test was 2 million cells per ml. ROUTINE respiration as supported by endogenous substrates was measured in mitochondrial respiration medium MIR05. After addition of rotenone (0.5 µM), succinate (10 mM), and ADP (2.5 mM), digitonin was titrated in steps of 1, 2, 3, 4, 6, 10 and 20 µg•ml -1 65 (Fig. 3 ). Reagents: All chemicals were from Sigma-Aldrich unless specified.
Statistical analysis:
The data are presented as medians (min-max). Comparing means with the medians showed differences <5% without affecting any statistical conclusions. Standard t-tests were used to calculate significance levels between the treatments (with or without IL-3). To determine the effects of addition of cytochrome c, or uncoupler, t-tests for dependent samples were used. Significance was considered at P <0.05.
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